Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

A 70-year-old presents with bone pain, serum calcium 11.8 mg/dL, creatinine 2.4 mg/dL, and a monoclonal protein of 4.2 g/dL on SPEP. Bone marrow shows 35% plasma cells. The lytic bone lesions in multiple myeloma are primarily caused by:

  • A RANK-L mediated osteoclast activation with simultaneous osteoblast inhibition
  • B Direct invasion by malignant plasma cells
  • C PTHrP secretion causing systemic hypercalcemia
  • D IL-6 driven osteocalcin suppression
Correct answer: A. RANK-L mediated osteoclast activation with simultaneous osteoblast inhibition

Explanation

Myeloma cells produce RANK-L (and suppress OPG), activating osteoclasts, while simultaneously producing DKK-1 and sclerostin to inhibit osteoblast function. This uncoupling of bone remodeling leads to pure lytic lesions without new bone formation, explaining the characteristic 'punched-out' lesions. PTHrP mediates humoral hypercalcemia of malignancy in solid tumors; IL-6 is a myeloma growth factor but does not primarily drive bone disease.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →